08:47 AM EDT, 09/08/2025 (MT Newswires) -- Belite Bio ( BLTE ) said Monday it is expecting to raise $275 million through a private placement in public equity financing process.

The company said it will raise $125 million financing upfront with up to an additional $150 million tied to the exercise of warrants.

The funding was led by RA Capital Management with participation from Eventide Asset Management, Marshall Wace, RTW Investments, Soleus Capital and Vestal Point Capital.

Belite Bio ( BLTE ) said the investors are subscribing to this offer by picking up a little over 1.95 million of its shares and warrants to purchase 1.95 million shares, at a purchase price of $64 per ordinary share and accompanying warrant.

Net proceeds from the transaction will be used for commercialization preparation, working capital and general corporate purposes. The transaction is expected to close by Tuesday.

Belite Bio ( BLTE ) shares were up more than 3% in recent premarket activity Monday.

Price: 67.76, Change: +2.02, Percent Change: +3.07